← Leaderboards
Bernhard Kuhn
Boston Children'S Hospital
$9,305,831
Attributed
$9,305,831
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,305,831 · 5
By mechanism
R01$8,660,531 · 4
K08$645,300 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Arin K. Greene$7,502,379
- Jane W. Newburger$29,827,102
- John K Triedman$3,858,283
- John Nagi Kheir$4,394,281
- Diane Renee Bielenberg$4,392,792
Others in their field
Top investigators on “Heart”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$118,439,174
- Deborah Nickerson · University Of Washington$86,844,068
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
HeartHeart FailureCardiac MyocytesProliferatingBirthInnovationSignal TransductionMyocardialIn VivoMyocardiumCell ProliferationCardiac RegenerationNatural RegenerationChildhoodCell DivisionChildInfantCongenital AbnormalityMolecularVentricularNeonatalCardiacCell CycleMorbidity - Disease Rate
Grant awards (27)
Mechanistic clinical trial of Beta-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$552,102
R01 · FY2025 · HL · contact PI
Mechanistic clinical trial of Beta-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$591,584
R01 · FY2024 · HL · contact PI
Mechanistic clinical trial of Beta-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$89,713
R01 · FY2024 · HL · contact PI
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$694,289
R01 · FY2023 · HL · contact PI
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation$327,590
R01 · FY2023 · HL · contact PI
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients$237,339
R01 · FY2023 · HL · contact PI
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients$178,161
R01 · FY2023 · HL · contact PI
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$77,541
R01 · FY2023 · HL · contact PI
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation$54,260
R01 · FY2023 · HL · contact PI
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$677,514
R01 · FY2022 · HL · contact PI
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients$415,167
R01 · FY2022 · HL · contact PI
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation$382,210
R01 · FY2022 · HL · contact PI
Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot$699,571
R01 · FY2021 · HL · contact PI
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients$411,500
R01 · FY2021 · HL · contact PI
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation$382,210
R01 · FY2021 · HL · contact PI
Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients$421,675
R01 · FY2020 · HL · contact PI
Lamin B2 regulates nuclear remodeling in cardiomyocyte terminal differentiation$382,210
R01 · FY2020 · HL · contact PI
Myofibril disassembly during neonatal heart muscle cell proliferation$379,225
R01 · FY2015 · HL · contact PI
Myofibril disassembly during neonatal heart muscle cell proliferation$426,300
R01 · FY2014 · HL · contact PI
Myofibril disassembly during neonatal heart muscle cell proliferation$414,120
R01 · FY2013 · HL · contact PI
Periostin in Myocardial Injury and Regeneration$129,060
K08 · FY2013 · HL · contact PI
Myofibril disassembly during neonatal heart muscle cell proliferation$435,000
R01 · FY2012 · HL · contact PI
Periostin in Myocardial Injury and Regeneration$129,060
K08 · FY2012 · HL · contact PI
Myofibril disassembly during neonatal heart muscle cell proliferation$431,250
R01 · FY2011 · HL · contact PI
Periostin in Myocardial Injury and Regeneration$129,060
K08 · FY2011 · HL · contact PI
Periostin in Myocardial Injury and Regeneration$129,060
K08 · FY2010 · HL · contact PI
Periostin in Myocardial Injury and Regeneration$129,060
K08 · FY2009 · HL · contact PI